Literature DB >> 20074733

Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis.

Yukihiko Momiyama, Reiko Ohmori, Zahi A Fayad, Teruyoshi Kihara, Nobukiyo Tanaka, Ryuichi Kato, Hiroaki Taniguchi, Masayoshi Nagata, Haruo Nakamura, Fumitaka Ohsuzu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20074733      PMCID： PMC3095031          DOI： 10.1016/j.atherosclerosis.2009.12.024

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  12 in total

1.  NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells.

Authors:  M Takemoto; M Kitahara; K Yokote; S Asaumi; A Take; Y Saito; S Mori
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Elevated plasma osteopontin levels were associated with osteopontin expression of CD4+ T cells in patients with unstable angina.

Authors:  Hirofumi Soejima; Atsushi Irie; Takashi Fukunaga; Koichi Sugamura; Sunao Kojima; Tomohiro Sakamoto; Michihiro Yoshimura; Hideki Kishikawa; Yasuharu Nishimura; Hisao Ogawa
Journal:  Circ J       Date:  2006-07       Impact factor: 2.993

3.  Association between osteopontin and human abdominal aortic aneurysm.

Authors:  Jonathan Golledge; Juanita Muller; Neil Shephard; Paula Clancy; Linda Smallwood; Corey Moran; Anthony E Dear; Lyle J Palmer; Paul E Norman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-14       Impact factor: 8.311

4.  Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes.

Authors:  Selçuk Coskun; Enver Atalar; Ercan Ozturk; Bunyamin Yavuz; Necla Ozer; Hakan Goker; Kenan Ovünç; Serdar Aksöyek; Sirri Kes; Bulent Sivri; Serafettin Kirazli; Ferhan Ozmen
Journal:  J Natl Med Assoc       Date:  2006-11       Impact factor: 1.798

5.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques.

Authors:  C M Giachelli; N Bae; M Almeida; D T Denhardt; C E Alpers; S M Schwartz
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

6.  Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification.

Authors:  S Hirota; M Imakita; K Kohri; A Ito; E Morii; S Adachi; H M Kim; Y Kitamura; C Yutani; S Nomura
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

7.  Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta.

Authors:  T Ikeda; T Shirasawa; Y Esaki; S Yoshiki; K Hirokawa
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Osteopontin is a constitutive component of normal elastic fibers in human skin and aorta.

Authors:  M Baccarani-Contri; F Taparelli; I Pasquali-Ronchetti
Journal:  Matrix Biol       Date:  1995-07       Impact factor: 11.583

9.  Plasma osteopontin levels are associated with the presence and extent of coronary artery disease.

Authors:  Reiko Ohmori; Yukihiko Momiyama; Hiroaki Taniguchi; Rie Takahashi; Masatoshi Kusuhara; Haruo Nakamura; Fumitaka Ohsuzu
Journal:  Atherosclerosis       Date:  2003-10       Impact factor: 5.162

10.  In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography.

Authors:  Hiroaki Taniguchi; Yukihiko Momiyama; Zahi A Fayad; Reiko Ohmori; Kazuhiro Ashida; Teruyoshi Kihara; Akiko Hara; Koh Arakawa; Akira Kameyama; Kumiko Noya; Masayoshi Nagata; Haruo Nakamura; Fumitaka Ohsuzu
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749
View more
  13 in total

1.  Urinary Osteopontin Predicts Incident Chronic Kidney Disease, while Plasma Osteopontin Predicts Cardiovascular Death in Elderly Men.

Authors:  Tobias Feldreich; Axel C Carlsson; Johanna Helmersson-Karlqvist; Ulf Risérus; Anders Larsson; Lars Lind; Johan Ärnlöv
Journal:  Cardiorenal Med       Date:  2017-05-25       Impact factor: 2.041

2.  Methylation of the FOXP3 upstream enhancer as a clinical indicator of defective regulatory T cells in patients with acute coronary syndrome.

Authors:  Jun Yang; Xiaoyang Yuan; Caixia Lv; Rong Bai; Le Zhang; Lei Ruang; Cuntai Zhang; Xiao-Qing Quan
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

3.  Osteopontin predicts long-term functional outcome among ischemic stroke patients.

Authors:  M Mendioroz; I Fernández-Cadenas; A Rosell; P Delgado; S Domingues-Montanari; M Ribó; A Penalba; M Quintana; J Alvarez-Sabín; J Montaner
Journal:  J Neurol       Date:  2010-10-22       Impact factor: 4.849

4.  Osteopontin in Vascular Disease.

Authors:  Zoe Shin Yee Lok; Alicia N Lyle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

5.  Levels of miR-130b-5p in peripheral blood are associated with severity of coronary artery disease.

Authors:  Neslihan Coban; Aybike Sena Ozuynuk; Aycan Fahri Erkan; Filiz Guclu-Geyik; Berkay Ekici
Journal:  Mol Biol Rep       Date:  2021-10-23       Impact factor: 2.316

6.  Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?

Authors:  Cristina Strobescu-Ciobanu; Simona Eliza Giuşcă; Irina Draga Căruntu; Cornelia Amălinei; Andreea Rusu; Elena Cojocaru; Radu Florin Popa; Cristian Dumitru Lupaşcu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

Review 7.  Osteopontin and Transplantation: Where Are We Now?

Authors:  Beata Kaleta
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-05-21       Impact factor: 4.291

8.  Progression of aortic arch calcification over 1 year is an independent predictor of mortality in incident peritoneal dialysis patients.

Authors:  Mi Jung Lee; Dong Ho Shin; Seung Jun Kim; Hyung Jung Oh; Dong Eun Yoo; Kwang Il Ko; Hyang Mo Koo; Chan Ho Kim; Fa Mee Doh; Jung Tak Park; Seung Hyeok Han; Tae-Hyun Yoo; Kyu Hun Choi; Shin-Wook Kang
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Protein targets of inflammatory serine proteases and cardiovascular disease.

Authors:  Ram Sharony; Pey-Jen Yu; Joy Park; Aubrey C Galloway; Paolo Mignatti; Giuseppe Pintucci
Journal:  J Inflamm (Lond)       Date:  2010-08-30       Impact factor: 4.981

10.  Osteopontin in relation to Prognosis following Coronary Artery Bypass Graft Surgery.

Authors:  Eftihia Sbarouni; Panagiota Georgiadou; Sofia Chatzikyriakou; Antonis Analitis; Antigoni Chaidaroglou; Demitris Degiannis; Vassilis Voudris
Journal:  Dis Markers       Date:  2016-08-14       Impact factor: 3.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.